Gene therapy biotech Homology Medicines increases proposed IPO deal size ahead of pricing – Nasdaq
Nasdaq |
Gene therapy biotech Homology Medicines increases proposed IPO deal size ahead of pricing
Nasdaq Homology Medicines, a preclinical biotech developing a gene therapy delivery platform for rare diseases, raised the proposed deal size for its upcoming IPO on Tuesday. The Bedford, MA-based company now plans to raise $135 million by offering 9 million … |
